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pre-immunization day 0, as well as on days 7-, 14-, 21-, 28-, and 58-post-immunization. Biochemical
parameters AST, ALT, alkaline phosphatase and bilirubin [total bilirubin (TB), direct bilirubin
(DB), and indirect bilirubin (IB)] were determined. On each experimental day, the mean values
of serum enzymes and bilirubin in group I and group II showed no signiﬁcant changes while in
group III, IV, V, and VI, these enzymes and bilirubin levels showed signiﬁcant changes
(p< 0.05), when compared with their experimental values within the group. The levels of serum
enzymes and bilirubin showed signiﬁcant difference (p< 0.05) in group III, IV, V, and VI on each
experimental day, when compared with the corresponding values of each other, and also compared
with the corresponding values of group I and II. Histamine, HTMT, pheniramine, and combination
of histamine + pheniramine cause hepatic function impairment in terms of altered serum enzymes
and bilirubin levels. The present ﬁndings suggest that HTMT causes moderate liver function impair-
ment while others show mild impairment.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Histamine H1 receptor (H1R) expression has been demon-
strated to change in the disorders such as allergic rhinitis,
autoimmune myocarditis, rheumatoid arthritis and athero-
sclerosis (Tripathi et al., 2010a). Histamine H1R antagonists
have a long history of clinical efﬁcacy in a variety of allergic
disorders. Several studies have reported changes in the
expression of H1R in pathological situations. Increased
expression of H1R was observed in the nasal mucosa of pa-
tients with allergic rhinitis and in cultured aortic intimal
smooth muscle cells of the patients suffering from atheroscle-
rosis (De Backer et al., 1998). Also, it has been documented
that up-regulation of the H1R expression might have a role
in the initiation and progression of cardiovascular disease. In-
creased H1R expression has been reported in the inﬂamed
joints of rheumatoid arthritis patients and in the heart of
mice with autoimmune myocarditis (De Backer et al.,
1998). Moreover, it has been demonstrated that the exacerba-
tion of asthmatic symptoms experienced by some women dur-
ing pregnancy is due to the enhanced expression of H1R in
nasal epithelial cells on induction by female sex hormones
(De Backer et al., 1998).
H1R antihistamines, known as histamine H1R blockers or
antagonists, are speciﬁc for the H1-receptor (De Backer et al.,
1998). Some H1R antagonists inhibit transmission through
the muscarinic, a-adrenergic, and serotonin receptors and also
through ion channels. The H1R-antihistamines have been
reclassiﬁed as inverse agonists, rather than as H1R antagonists,
which is consonant with an increased understanding of their
molecular pharmacologic features (Simons, 2004). More than
40 H1R antagonists are available worldwide, indeed these
H1R ligands are among themost widely used of all medications.
However, the H1R antagonists (astemizole and terfenadine),
which are associated with cardiac toxic effects, are no longer ap-
proved for use (Simons, 2004). Both health care professionals
and consumers assume that all the approved H1R antagonists
have been shown to be efﬁcacious and safe, but several medica-
tions in this class have not been optimally studied in random-
ized, double-blind, controlled trials (Simons, 2004).
First and second-generation H1R antagonists are reported
to cause adverse effects, the mechanisms for which are incom-
pletely understood. These effects include ﬁxed-drug eruption,
photosensitivity, urticaria, fever, elevation of liver enzymes
and hepatitis, and agranulocytosis (Simons, 2004).Recently, it has been demonstrated that histamine receptors
(HR) on induction via their speciﬁc agonist can stimulate
hypertrophy and hyperplasia of respiratory tract epithelium,
and suggested HR agonists’ role akin to growth stimulating
factor (Dilkash et al., 2010).
Liver is a vital organ for the biotransformation of xenobiot-
ics and therefore is also exposed to drug toxicity including his-
tamine and HR ligands (Tripathi et al., 2010b). Histamine
acting via histamine H2R pathway is believed to protect the
liver against early alcohol-induced liver injury in rats (Hornyak
et al., 2003) and also plays a role in the treatment of endotoxin-
induced hepatic injury and related inﬂammatory disorders
(Masaki et al., 2005). Interestingly, different drugs acting
through the same receptors show different roles on the same
biological process e.g., H2R antagonists like cimetidine and
ranitidine have inhibitory effect on liver regeneration but famo-
tidine has no such effect (Kanashima and Kobayashi, 1989). It
has also been demonstrated that modest inﬂammation predis-
poses liver to ranitidine toxicity in rats and suggested a role
for the inﬂammation in idiosyncratic reactions to ranitidine
(Luyendyk et al., 2003).
In contrast to studies on histamine and HR agonists and
antagonists in various pathological conditions the data on
H1R agonists and antagonists on hepatic functions are ele-
mentary in the existing literature. This prompted us to look
for their roles in hepatotoxicity (if any) in albino rabbits by
using liver function test.
2. Materials and methods
2.1. Experimental design
To evaluate the serum level of liver enzymes and bilirubin, 108
(54 male and 54 female) New Zealand adult healthy albino
rabbits of either sex weighing 1.0–1.5 kg were randomized
equally into six treatment groups. Each group contained 18
(9 male and 9 female) rabbits. All groups were immunized with
sheep red blood cells (SRBC). Group I (negative control) and
group II (positive control) received vehicle (sterile distilled
water, 1 ml/kg · b.i.d.) while groups III, IV, V, and VI were
treated with histamine, H1R agonist, H1R antagonist and
H1R antagonist + histamine, respectively.
They were housed in a well maintained animal facility at
Central Animal House, J. N. Medical College, Aligarh Muslim
University, Aligarh, in the Bioresources unit under 12 h light/
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access to standard laboratory diet, including green vegetables,
and tap water until experimentation. All the studies were
carried out during the light cycle and were approved by the
Institutional Animal Ethical Committee.
2.2. Drugs
Histamine dihydrochloride was purchased from Himedia Lab-
oratories Pvt. Limited, India.
H1R agonist (histamine triﬂuoro-methyl toluidide (HTMT)-
dimaleate) was kindly donated by Tocris Bioscience, Tocris
Cookson Ltd., United Kingdom; H1R antagonist [Avil (phe-
niramine maleate)] in injection I.P. from Unimark Remedies,
India.
2.3. Dosage regimen
Histamine dihydrochloride 100 lg/kg and H1R agonist
(HTMT-dimaleate) 10 lg/kg were administered through sub-
cutaneous (s.c.) route, and H1R antagonist (pheniramine
maleate) 10 mg/kg was administered through intramuscular
(i.m.) route; twice in a day [12 hourly (8 am and 8 pm)] for
10 days (starting from 3 days prior to immunization until
7 days after immunization). All doses referred to the weight
of the salts used.
2.4. Antigen
Sheep blood diluted 1:1 in sterile Alsevier’s solution was
obtained from the Department of Microbiology, J. N. Medical
College, A.M.U., Aligarh, and washed with PBS (pH 7.4)
thrice by centrifugation. The cell suspensions were adjusted
to the desired concentration in terms of hemoglobin, lysis of
a 1% SRBC suspension (2 · 108 cells/ml) with 14 volumes of
0.1% Na2CO3 develops an optical density of 0.135 at 541 nm
in a spectrophotometer (Systronics, UV–visible double beam
spectrophotometer-2101, India) (Tripathi et al., 2010c–g). Fi-
nally the concentration was adjusted to 5% (1 · 109 cells/ml)
in PBS for immunization before use.
2.5. Immunization of rabbits
All the rabbits in the study groups (II–VI) were immunized on
day 3 intravenously (i.v.) with 1 ml of 5% (1 · 109 cells/ml)
sheep red blood cells (SRBC) in PBS.
2.6. Biochemical analyses
To determine the biochemical levels for liver function, blood
samples were collected from rabbits through the marginal ear
veins prior to immunization (day 0), as well as on days 7-,
14-, 21-, 28-, and 58-post-I. Blood samples were kept at room
temperature for 2 h and then at 4 C overnight. Blood samples
were centrifuged for 10 min at 580·g, and serum was separated
and heated at 56 C for 30 min to inactivate the complement
proteins and stored in aliquots containing sodium azide as a
preservative at20 C. Serum levels of liver enzymes, including
aspartate aminotransferase (AST), alanine aminotransferase
(ALT), alkaline phosphatase (ALP), and bilirubin [total biliru-bin (TB), direct bilirubin (DB), and indirect bilirubin (ID)] were
determined using an automatic analyzer (Transasia XL 300,
Germany).
2.7. Statistical analyses
Data were summarized as Mean ± SD. Groups were com-
pared by using repeated measures (subjects within groups)
two way analysis of variance (ANOVA) followed by New-
man–Keuls post hoc test. A two-tailed (a= 2) probability
p< 0.05 was considered to be statistically signiﬁcant. Analyses
were performed on SPSS for windows (version 12.0, Inc.,
Chicago, IL).3. Results
The changes in the mean values of serum level of serum
enzymes (ALT, AST, and ALP) and bilirubin (TB, DB, and
IB) in group I–VI are shown in Figs. 1–6, respectively.
On each experimental day, the mean values of serum level
of serum enzymes (ALT, AST, and ALP) and bilirubin (TB,
DB, and IB) in group I (negative control) and group II (posi-
tive control) showed no signiﬁcant changes, when compared
with the experimental values of serum enzymes and bilirubin
within the group, and also compared with the corresponding
values of each other. In groups III–VI, these enzymes and
bilirubin levels showed changes on each experimental day,
when compared with the experimental values of serum
enzymes and bilirubin within the group.
Furthermore, the levels of serum enzymes and bilirubin
showed signiﬁcant difference (p< 0.05) in groups III–VI on
each experimental day, when compared with the correspond-
ing values of each other, and also compared with the corre-
sponding values of groups I and II.4. Discussion
It has been demonstrated that liver of rabbits was markedly
damaged by histamine and HR (H1R, H2R, H3R, and
H4R) agonist (Tripathi et al., 2010b). The damage caused by
short-term exposure to histamine and HR agonist appeared
quite speciﬁc for each of the agonist (Tripathi et al., 2010b).
In general, increased incidence of hepatocyte polyploidy (bi-
and multinucleated), frequent occurrence of Kupffer cells
(KCs), variable grades of necrosis, congestion, and lympho-
cytic inﬁltration constituted the hallmark of injuries were
observed in histamine and HR agonist treated rabbits
(Tripathi et al., 2010b). Moreover, it has been shown that
the elevation of endogenous histamine by amodiaquine (a his-
tamine N methyltransferase inhibitor) plays a protective role
through the regulation of TNF-a production in endotoxin-
induced hepatic injury in mice (Yokoyama et al., 2007).
Imoto et al. (1985) suggesting that histamine by H1R plays
an important role in liver function. In addition to this, we have
designed our study to explore histamine and H1R agonist and
antagonist induced liver functions in immunized [with SRBC,
a T cell-dependent test antigen (Tripathi et al., 2010c–g)] and
non-immunized rabbits.
The abnormalities in liver function tests (LFTs) are ele-
vated levels of static biochemical tests, including liver enzymes
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Figure 1 Effects of histamine and histamine H1-receptor agonist and antagonist on serum ALT levels. The results demonstrate
mean ± s.d. of three experiments each with six rabbits. Two-way ANOVA followed by Newman–Keuls post hoc test revealed that the
effect of treatments (F= 1163.937, DF = 5102; p< 0.01) and days (F= 237.363, DF = 5510; p< 0.01) on SRBC were statistically
signiﬁcant. The interaction (treatments · days) effect of (F= 285.644, DF = 25,510; p< 0.01) these on SRBC was also found to be
signiﬁcant.
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Figure 2 Effects of histamine and histamine H1-receptor agonist and antagonist on serum AST levels. The results demonstrate
mean ± s.d. of three experiments each with six rabbits. Two-way ANOVA followed by Newman–Keuls post hoc test revealed that the
effect of treatments (F= 482.721, DF = 5102; p< 0.01) and days (F= 122.566, DF = 5510; p< 0.01) on SRBC were statistically
signiﬁcant. The interaction (treatments · days) effect of (F= 177.821, DF = 25,510; p< 0.01) these on SRBC was also found to be
signiﬁcant.
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are the biochemical parameters of liver damage (Masakiet al., 2005; Thapa and Walia, 2007). The biotransformation
of xenobiotics takes place in liver (Maciejewska-Paszek et al.,
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Figure 3 Effects of histamine and histamine H1-receptor agonist and antagonist on serum alkaline phosphatase (ALP) levels. The results
demonstrate mean ± s.d. of three experiments each with six rabbits. Two-way ANOVA followed by Newman–Keuls post hoc test
revealed that the effect of treatments (F= 696.678, DF = 5102; p< 0.01) and days (F= 742.821, DF = 5510; p< 0.01) on SRBC were
statistically signiﬁcant. The interaction (treatments · days) effect of (F= 276.182, DF = 25,510; p< 0.01) these on SRBC was also found
to be signiﬁcant.
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Figure 4 Effects of histamine and histamine H1-receptor agonist and antagonist on serum total bilirubin (TB) levels. The results
demonstrate mean ± s.d. of three experiments each with six rabbits. Two-way ANOVA followed by Newman–Keuls post hoc test
revealed that the effect of treatments (F= 775.278, DF = 5102; p< 0.01) and days (F= 199.418, DF = 5510; p< 0.01) on SRBC were
statistically signiﬁcant. The interaction (treatments · days) effect of (F= 134.927, DF = 25,510; p< 0.01) these on SRBC was also found
to be signiﬁcant.
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required by clinical practitioners for examining liver damage.The most common abnormalities of LFTs in an asymptomatic
person are increased ALT and AST. The upper normal limits
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Figure 5 Effects of histamine and histamine H1-receptor agonist and antagonist on serum direct bilirubin (DB) levels. The results
demonstrate mean ± s.d. of three experiments each with six rabbits. Two-way ANOVA followed by Newman–Keuls post hoc test
revealed that the effect of treatments (F= 469.121, DF = 5102; p< 0.01) and days (F= 142.24, DF = 5510; p< 0.01) on SRBC were
statistically signiﬁcant. The interaction (treatments · days) effect of (F= 111.402, DF = 25,510; p< 0.01) these on SRBC was also found
to be signiﬁcant.
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Figure 6 Effects of histamine and histamine H1-receptor agonist and antagonist on serum indirect bilirubin (IB) levels. The results
demonstrate mean ± s.d. of three experiments each with six rabbits. Two-way ANOVA followed by Newman–Keuls post hoc test
revealed that the effect of treatments (F= 71.109, DF = 5102; p< 0.01) and days (F= 6.737, DF = 5510; p< 0.01) on SRBC were
statistically signiﬁcant. The interaction (treatments · days) effect of (F= 7.876, DF = 25,510; p< 0.01) these on SRBC was also found
to be signiﬁcant.
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AST and ALT reﬂect liver degeneration. Both AST and ALTmay be raised in patients with muscle injury (Hasan and
Owyed, 2003). In most liver diseases, AST/ALT ratio is <1.
The Inﬂuence of histamine H1-receptor on liver functions in immunized rabbits 417However, in alcoholic liver disease (alcoholic steatosis,
alcoholic hepatitis, and cirrhosis), AST/ALT is >1, and is
usually >2 (Sorbi et al., 1999). Mild to moderate elevations
in serum ALT and AST levels may be observed in virtually
all liver diseases, and thus are generally nonspeciﬁc (Mathiesen
et al., 1999). ALT and AST levels exceeding 15 times the upper
limit of normal are usually found in a limited number of con-
ditions (i.e. drugs, acute viral hepatitis, ischemic hepatitis,
autoimmune hepatitis, common bile duct stones and muscle in-
jury) (Fortson et al., 1985; Johnson et al., 1995; Mathiesen
et al., 1999). ALT and AST are sensitive markers of hepatocel-
lular injury but they lack speciﬁcity as they are also present in
muscle (cardiac and skeletal), kidney and red blood cells (Yap
and Aw, 2010). Serum alkaline phosphatase (ALP) activity
may derive from liver, bone, intestine, and placenta. Various
hepatobiliary (such as drugs, bile duct obstruction, primary
biliary cirrhosis, primary sclerosing cholangitis, liver metasta-
sis, inﬁltrative liver disease, viral hepatitis, alcoholic hepatitis,
and cirrhosis) and non-hepatic (bone disease, pregnancy,
chronic renal failure, congestive heart failure, childhood
growth, and malignancy) causes are related with raised ALP.
However, low serum ALP in patients with biochemical evi-
dence of liver dysfunction may be a clue to Wilson’s disease.
Also, low ALP may be encountered in hypothyroidism, zinc
deﬁciency, pernicious anemia, and congenital hypophosphate-
mia (Hasan and Owyed, 2003). The results of this study
revealed that groups III–VI show impaired serum levels of
ALT, AST, and ALP. This study shows moderate alterations
in serum levels of ALT, AST, and ALP in group IV (HTMT)
while group III (histamine), group V (pheniramine), and group
VI (pheniramine+histamine) show mild impairment. Thus,
serum levels of ALT and AST impairment represent liver dam-
age in the order: HTMT> pheniramine > pheniramine+his-
tamine > histamine, when compared with positive control and
negative control.
Furthermore, serum bilirubin is a mixture of a, b, c, and d
fragments which are unconjugated, singly conjugated, doubly
conjugated, and covalently bound to albumin, respectively
(Yap and Aw, 2010). Although d bilirubin measurement is
available, it has not gained wider utility. In most cases a total
bilirubin (TB) assay sufﬁces for LFT, but fractionation may
be required in isolated increases in bilirubin and neonatal
jaundice. Direct bilirubin (DB) refers to the conjugated biliru-
bins that react directly with the diazo reagent, while indirect
bilirubin (IB) is a derived value obtained from the difference
of TB and DB. DB assays measure only 70–90% of the con-
jugated and d bilirubins, and may underestimate the severity
of jaundice (Yap and Aw, 2010). Fractionation of serum bil-
irubin is useful in separating the causes of jaundice. In prehe-
patic jaundice due to hemolysis, unconjugated bilirubin is
increased with little or no increase in conjugated bilirubin.
In hepatic and post-hepatic jaundice, there is increased conju-
gated and d bilirubin (Yap and Aw, 2010). When the liver
function tests are abnormal and the serum bilirubin levels
more than 17 lmol/L suggest underlying liver disease (Fried-
man et al. 2003; Thapa and Walia, 2007). The bilirubin re-
sults of this study revealed that the serum levels of TB,
DB, and IB in groups III-VI show liver function impairment
in the order: histamine > HTMT> pheniramine+hista-
mine > pheniramine, when compared with positive control
and negative control.It is therefore concluded that histamine, HTMT (H1R
agonist), pheniramine (H1R antagonist), and combination of
pheniramine+histamine cause hepatic function impairment
in terms of altered serum enzymes and bilirubin levels. Thus,
the present ﬁndings suggest that HTMT causes moderate liver
function impairment while others show mild impairment war-
ranting further long-term studies. This study would deﬁnitely
stimulate active discussions about the effects of histamine
and its HR agonists and antagonists on hepatic functions.
To the best of our knowledge, this is the ﬁrst report describing
a comparative study of histamine and H1R agonist and antag-
onist on liver function in immunized and non-immunized
rabbits.
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